首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal IVD Antibody

  • 中文名： IVD抗体
  • 别    名： ACAD2
货号: IPDX09713
Price： ￥1180
数量：
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 咨询技术 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 1/5000-1/10000 Human,Mouse,Rat

产品详情

AliasesACAD2
WB Predicted band size46 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse, Rat
ImmunogenFusion protein of human IVD
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

参考文献

以下是关于IVD(体外诊断)抗体的示例性参考文献，结构包含文献名称、作者及摘要概括。注：以下内容为示例，非真实存在的文献。

---

1. **文献名称**：*Development of High-Specificity Monoclonal Antibodies for SARS-CoV-2 Antigen Detection*

**作者**：Smith A, et al. (2020)

**摘要**：本研究报道了针对SARS-CoV-2核衣壳蛋白的单克隆抗体的开发，通过ELISA和侧向层析技术验证其在临床样本中的高灵敏度和特异性，为COVID-19快速诊断试剂盒提供了核心原料。

2. **文献名称**：*Dual-Antibody Sandwich Assays for Early Cancer Biomarker Detection*

**作者**：Jones B, et al. (2018)

**摘要**：文章评估了两种单克隆抗体在双抗夹心法中对血清中癌胚抗原(CEA)的检测性能，证明其在低浓度样本中仍保持优异的一致性，推动了结直肠癌筛查的临床应用。

3. **文献名称**：*Recombinant Antibodies in IVD: A Comparative Study with Polyclonal Counterparts*

**作者**：Lee C, et al. (2021)

**摘要**：通过对比重组抗体与传统多克隆抗体在心肌肌钙蛋白检测中的表现，研究发现重组抗体具有更高的批间一致性及更低的交叉反应性，为IVD试剂的标准化生产提供依据。

4. **文献名称**：*Stability and Quality Control of Antibody Reagents in Diagnostic Kits*

**作者**：Zhang Y, et al. (2019)

**摘要**：系统分析了温度、保存时间对抗体试剂性能的影响，提出优化储存条件可显著延长试剂保质期，为IVD产品的质量控制标准制定提供数据支持。

---

**说明**：以上文献为示例，聚焦IVD抗体的开发、应用场景(传染病、癌症)、技术优化(重组抗体)及质控环节，覆盖该领域的关键研究方向。实际研究中建议通过PubMed或Web of Science检索真实文献。

背景信息

In vitro diagnostic (IVD) antibodies are specialized immunoglobulins engineered for detecting and quantifying biomarkers in clinical samples. They serve as critical components in immunoassays (e.g., ELISA, chemiluminescence, lateral flow tests) to diagnose diseases, monitor treatment efficacy, or assess health conditions. IVD antibodies target antigens associated with infectious diseases (e.g., COVID-19. HIV), cancers, cardiac disorders, and autoimmune conditions. Their development leverages hybridoma or recombinant antibody technologies, ensuring high specificity and sensitivity. Monoclonal antibodies dominate due to batch consistency, while polyclonal antibodies are used for multi-epitope detection. Rigorous validation ensures minimal cross-reactivity and stability under diagnostic conditions. The global IVD antibody market is driven by rising chronic diseases, demand for rapid diagnostics, and advancements in precision medicine. Emerging trends include CRISPR-engineered antibodies, nanobody-based assays, and multiplex platforms integrating AI for data interpretation. Challenges include optimizing affinity for low-abundance biomarkers and addressing regulatory requirements. As personalized healthcare expands, IVD antibodies remain pivotal in enabling early, accurate diagnoses and improving patient outcomes through targeted therapeutic strategies.

客户数据及评论

折叠内容

大包装询价

×